Fibromyalgia Treatment Market Analysis

Drug Class (Antidepressants, Antiepileptic, Muscle Relaxants)

The global fibromyalgia treatment market is segmented and analyzed for demand and supply by drug class into antidepressants, antiepileptics, muscle relaxants, and others. Out of the these, types of drug-class antiepileptics segment is estimated to gain the largest market share over the projected time frame. Anticonvulsants, usually referred to as antiepileptic medications, are frequently prescribed to treat epilepsy, and on the other hand, they have also been used to treat fibromyalgia. The FDA has approved the antiepileptic drug pregabalin for the treatment of fibromyalgia. Pregabalin blocks the release of substances P, norepinephrine, and glutamate, which may significantly help fibromyalgia patients feel less pain. Depending on the patient's creatinine clearance, pregabalin must be begun at 75 mg twice daily and gradually increased to 225 mg twice daily. Total daily doses of 300 mg, 450 mg, or 600 mg can lessen pain by more than 30% if the patient can bear the side effects of drowsiness, dry mouth, added weight, and oedema. The market for antidepressants, is anticipated to hold the second largest share over the forecast period. The signs of depression may be lessened with the aid of antidepressants. Additionally, they can help in the treatment of seasonal affective disorder and social anxiety disorder. There is growing evidence that, to a limited extent, antidepressants are effective therapies for fibromyalgia. Antidepressants change specific neurotransmitters in the brain, and these same neurotransmitters play a role in fibromyalgia. One of the most popular forms of treatment is amitriptyline and other tricyclic antidepressants (TCAs). Newer antidepressants have undergone thorough fibromyalgia testing since they are better tolerated than tricyclics. Instead of acting as an antidepressant, cyclobenzaprine, a tricyclic substance that varies from amitriptyline only by one double bond, relaxes the muscles.

Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

The global fibromyalgia treatment market is also segmented and analyzed for distribution by distribution into retail pharmacies, hospital pharmacies, and online pharmacies. Amongst these three segments, the retail pharmacies segment is expected to garner a significant share. Any pharmacy that dispenses, stocks, or sells prescription drugs to the general public is considered retail pharmacy. Any consumer can pick up their medication at a retail pharmacy without first acquiring a prescription. Moreover, the customers have direct contact with the retailer. A reputable company that sells medicines and related goods is a retail pharmacy. Since hospitalization is not always necessary for fibromyalgia therapy, retail pharmacies are expected to gain market share during the anticipated period. Hospital pharmacies, which were expected to expand at the greatest CAGR, were the second-largest market in 2021. Integrated into the care of a medical facility is the subsection of pharmacy known as a hospital pharmacy. These include residential care institutions, hospitals, outpatient clinics, drug addiction treatment centers, poison control centers, and drug resource centers. The job involves choosing, preparing, storing, compounding, and dispensing drugs for patients in a medical setting. Hospital pharmacies' primary responsibility in patient care is risk management.

Our in-depth analysis of the global market includes the following segments: